<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" 
     xmlns:content="http://purl.org/rss/1.0/modules/content/"
     xmlns:wfw="http://wellformedweb.org/CommentAPI/"
     xmlns:dc="http://purl.org/dc/elements/1.1/"
     xmlns:meneame="http://meneame.net/faq-es.php"
 >
<channel>
	<title>Menéame: comentarios [2139476]</title>
	<link>http://www.meneame.net</link>
	<image><title>www.meneame.net</title><link>http://www.meneame.net</link><url>http://cdn.mnmstatic.net/img/mnm/eli-rss.png</url></image>
	<description>Sitio colaborativo de publicación y comunicación entre blogs</description>
	<pubDate>Thu, 20 Mar 2014 09:16:48 +0000</pubDate>
	<generator>http://blog.meneame.net/</generator>
	<language>es</language>
	<item>
		<meneame:comment_id>14454817</meneame:comment_id>
		<meneame:link_id>2139476</meneame:link_id>
		<meneame:order>3</meneame:order>
		<meneame:user>Die_Spinne</meneame:user>
		<meneame:votes>1</meneame:votes>
		<meneame:karma>16</meneame:karma>
		<meneame:url>https://www.meneame.net/story/bevacizumab-hito-tratamiento-cancer-ovario</meneame:url>
		<title>#3 Bevacizumab, un “hito” en el tratamiento del cáncer de ovario</title>
		<link>https://www.meneame.net/story/bevacizumab-hito-tratamiento-cancer-ovario/c03#c-3</link>
		<pubDate>Thu, 20 Mar 2014 09:16:48 +0000</pubDate>
		<dc:creator>Die_Spinne</dc:creator>
		<guid>https://www.meneame.net/story/bevacizumab-hito-tratamiento-cancer-ovario/c03#c-3</guid>
		<description><![CDATA[<p>De la misma familia que el cetuximab que tanto bien ha hecho y sigue haciendo en otros tumores ecamosos, cada avance, sea para el tipo de cancer que sea nos insufla nuevas esperanzas a las familias de los enfermos hoy en tratamiento.</p><p>&#187;&nbsp;autor: <strong>Die_Spinne</strong></p>]]></description>
	</item>

	<item>
		<meneame:comment_id>14454717</meneame:comment_id>
		<meneame:link_id>2139476</meneame:link_id>
		<meneame:order>2</meneame:order>
		<meneame:user>soyrod</meneame:user>
		<meneame:votes>0</meneame:votes>
		<meneame:karma>11</meneame:karma>
		<meneame:url>https://www.meneame.net/story/bevacizumab-hito-tratamiento-cancer-ovario</meneame:url>
		<title>#2 Bevacizumab, un “hito” en el tratamiento del cáncer de ovario</title>
		<link>https://www.meneame.net/story/bevacizumab-hito-tratamiento-cancer-ovario/c02#c-2</link>
		<pubDate>Thu, 20 Mar 2014 09:00:46 +0000</pubDate>
		<dc:creator>soyrod</dc:creator>
		<guid>https://www.meneame.net/story/bevacizumab-hito-tratamiento-cancer-ovario/c02#c-2</guid>
		<description><![CDATA[<p><a class="tooltip c:2139476-1" href="https://www.meneame.net/story/bevacizumab-hito-tratamiento-cancer-ovario/c01#c-1" rel="nofollow">#1</a> Jajajaja De todo se aprende!!!</p><p>&#187;&nbsp;autor: <strong>soyrod</strong></p>]]></description>
	</item>

	<item>
		<meneame:comment_id>14454669</meneame:comment_id>
		<meneame:link_id>2139476</meneame:link_id>
		<meneame:order>1</meneame:order>
		<meneame:user>Robus</meneame:user>
		<meneame:votes>1</meneame:votes>
		<meneame:karma>23</meneame:karma>
		<meneame:url>https://www.meneame.net/story/bevacizumab-hito-tratamiento-cancer-ovario</meneame:url>
		<title>#1 Bevacizumab, un “hito” en el tratamiento del cáncer de ovario</title>
		<link>https://www.meneame.net/story/bevacizumab-hito-tratamiento-cancer-ovario/c01#c-1</link>
		<pubDate>Thu, 20 Mar 2014 08:51:27 +0000</pubDate>
		<dc:creator>Robus</dc:creator>
		<guid>https://www.meneame.net/story/bevacizumab-hito-tratamiento-cancer-ovario/c01#c-1</guid>
		<description><![CDATA[<p>fuente correcta no AEDE! votado! <img data-src="https://cdn.mnmstatic.net/v_149/img/menemojis/36/smiley.png" alt=":-)" title=":-)" width="18" height="18" src="https://cdn.mnmstatic.net/v_149/img/g.gif" class="emoji lazy" /></p><p>&#187;&nbsp;autor: <strong>Robus</strong></p>]]></description>
	</item>

</channel>
</rss>
